Natera, Inc. (NASDAQ:NTRA – Get Free Report) insider Jonathan Sheena sold 351 shares of Natera stock in a transaction dated Monday, January 22nd. The shares were sold at an average price of $68.16, for a total value of $23,924.16. Following the completion of the transaction, the insider now directly owns 469,726 shares of the company’s […]
Principal Financial Group Inc. lifted its stake in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 8.2% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 1,590,790 shares of the medical research company’s stock after buying an additional 120,225 shares during the quarter. Principal […]
Shares of Natera, Inc. (NASDAQ:NTRA – Get Free Report) have been given an average rating of “Buy” by the twelve brokerages that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, ten have issued a buy recommendation and one has assigned a strong buy recommendation […]
Natera, Inc. (NASDAQ:NTRA – Get Free Report) insider Jonathan Sheena sold 5,000 shares of Natera stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $60.30, for a total value of $301,500.00. Following the completion of the transaction, the insider now directly owns 469,743 shares in the company, […]
Natera (NASDAQ:NTRA – Free Report) had its price objective increased by BTIG Research from $75.00 to $85.00 in a research note published on Friday morning, Marketbeat.com reports. BTIG Research currently has a buy rating on the medical research company’s stock. Several other research firms have also recently weighed in on NTRA. StockNews.com initiated coverage on […]